Ohio Public Employees Retirement System (OPERS)’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-14,769
Closed -$677K 2000
2022
Q4
$677K Sell
14,769
-3,810
-21% -$164K ﹤0.01% 1238
2022
Q3
$900K Hold
18,579
﹤0.01% 1232
2022
Q2
$730K Sell
18,579
-19,051
-51% -$767K ﹤0.01% 1301
2022
Q1
$1.39M Sell
37,630
-28,999
-44% -$1.03M ﹤0.01% 1188
2021
Q4
$3.04M Hold
66,629
0.01% 972
2021
Q3
$2.38M Hold
66,629
0.01% 1059
2021
Q2
$1.32M Hold
66,629
﹤0.01% 1216
2021
Q1
$1.55M Hold
66,629
0.01% 1133
2020
Q4
$1.39M Sell
66,629
-14,200
-18% -$260K 0.01% 1110
2020
Q3
$1.75M Hold
80,829
0.01% 915
2020
Q2
$1.91M Sell
80,829
-13,815
-15% -$259K 0.01% 929
2020
Q1
$1.12M Buy
94,644
+10,752
+13% +$137K 0.01% 1010
2019
Q4
$890K Buy
83,892
+7,897
+10% +$81.1K ﹤0.01% 1179
2019
Q3
$865K Sell
75,995
-23,330
-23% -$293K ﹤0.01% 1214
2019
Q2
$1.12M Sell
99,325
-9,550
-9% -$92.1K 0.01% 1166
2019
Q1
$881K Buy
108,875
+25,488
+31% +$187K ﹤0.01% 1246
2018
Q4
$527K Buy
83,387
+21,268
+34% +$156K ﹤0.01% 1271
2018
Q3
$612K Sell
62,119
-11,410
-16% -$91.6K ﹤0.01% 1347
2018
Q2
$610K Hold
73,529
﹤0.01% 1377
2018
Q1
$529K Sell
73,529
-6,951
-9% -$59.6K ﹤0.01% 1371
2017
Q4
$656K Buy
80,480
+54,333
+208% +$617K ﹤0.01% 1335
2017
Q3
$379K Sell
26,147
-24,919
-49% -$340K ﹤0.01% 1429
2017
Q2
$618K Hold
51,066
﹤0.01% 1310
2017
Q1
$656K Hold
51,066
﹤0.01% 1262
2016
Q4
$539K Hold
51,066
﹤0.01% 1304
2016
Q3
$469K Hold
51,066
﹤0.01% 1318
2016
Q2
$485K Buy
51,066
+32,360
+173% +$266K ﹤0.01% 1259
2016
Q1
$132K Hold
18,706
﹤0.01% 1465
2015
Q4
$196K Buy
18,706
+11,368
+155% +$111K ﹤0.01% 1384
2015
Q3
$49K Buy
+7,338
New +$50.1K ﹤0.01% 1775

Other funds holding CYTK

Ohio Public Employees Retirement System (OPERS)'s CYTK Position: Q1 2023 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Cytokinetics (CYTK) in Q1 2023, closing a stake of 14,769 shares — an estimated $677K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in CYTK in Q3 2015 and held it in 30 quarters. The position peaked at $3.04M in Q4 2021. 262 funds tracked by Wall St. Rank hold CYTK as of Q1 2023.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining Cytokinetics position as of Q1 2023 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 14,769 Cytokinetics shares in Q1 2023, an estimated $677K.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Cytokinetics in Q3 2015 and held it in 30 quarters.
  • Ohio Public Employees Retirement System (OPERS)'s Cytokinetics position peaked at $3.04M in Q4 2021.
  • 262 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2023.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q1 2023, filed 15 May 2023.